Riferimento farmaci
Glatiramer
Glatiramer is a medicine in the class central nervous system. It is used for multiple sclerosis.
- Classe del farmaco: Central Nervous System
- Indicato per: multiple sclerosis
Ultimo aggiornamento Fonti: US FDA label
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
In breve
- Classe del farmaco
- Central Nervous System
- Forme farmaceutiche comuni
- iniezione
- Dosaggi comuni
- 20 mg/ml, 40 mg/ml
- Interazioni note
- 18 (Minore: 18)
- Nomi commerciali
- 4
- Paesi e mercati
- 2
Per cosa si usa
Come agisce
Mechanism in MS is not fully understood; thought to act by modifying immune processes believed responsible for MS pathogenesis. Animal and in vitro studies suggest induction and activation of glatiramer acetate-specific suppressor T-cells in the periphery.
Dose abituale nell'adulto (sintesi del foglio illustrativo)
Relapsing forms of multiple sclerosis: Glatopa 20 mg per mL, subcutaneous, once per day
Gravidanza e allattamento
- Gravidanza
- Unknown Pharmacovigilance and observational data have not identified a drug-associated risk of major birth defects, miscarriage, or adverse outcomes; no adverse effects in rats or rabbits.
- Allattamento
- Unknown No data on presence in human milk; low systemic exposure means clinically relevant infant exposure is not expected. Weigh benefits of breastfeeding against maternal need.
Effetti indesiderati segnalati
- Injection site erythema
- Injection site pain
- Injection site pruritus
- Injection site mass
- Vasodilatation
- Rash
Avvertenze in evidenza
- Life-threatening and fatal anaphylaxis has been reported, and can occur at any time after starting therapy, from after the first dose to years later. Make patients aware of symptoms, which may overlap with immediate post-injection reaction, and instruct them to seek immediate medical care. Contraindicated in patients with prior hypersensitivity, including anaphylaxis. If anaphylaxis occurs, discontinue immediately and permanently unless a clear alternative etiology is identified.
Controindicazioni
- Known hypersensitivity to glatiramer acetate or mannitol; reactions have included anaphylaxis.
Chi deve prestare attenzione
- Immediate post-injection reaction (flushing, chest pain, palpitations, tachycardia, anxiety, dyspnea, throat constriction, urticaria) may occur within seconds to minutes after injection; usually transient.
- Transient chest pain may occur, often unrelated to injection.
- Lipoatrophy and rarely skin necrosis may occur at injection sites; lipoatrophy is thought to be permanent. Use proper technique and rotate sites.
Informare il farmacista o il medico di gravidanza o allattamento, malattie renali o epatiche, allergie e di ogni altro farmaco o integratore assunto.
Interazioni principali (18)
- Anakinra + Glatiramer Minor
- Anti-thymocyte + Glatiramer Minor
- Basiliximab + Glatiramer Minor
- Denosumab + Glatiramer Minor
- Echinacea + Glatiramer Minor
- Etanercept + Glatiramer Minor
- Glatiramer + Golimumab Minor
- Glatiramer + Hepatitis A vaccine inactivated Minor
- Glatiramer + Human papillomavirus vaccine Minor
- Glatiramer + Leflunomide Minor
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per aprire la monografia completa di Glatiramer: dosi, gravidanza e allattamento, effetti indesiderati, avvertenze e tutte le interazioni.
- How to give it
- Pharmacokinetics
- Patient counselling points
Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.
Altri farmaci della stessa classe
Domande frequenti
What is Glatiramer used for?
Glatiramer is a medicine in the class central nervous system. It is used for Multiple sclerosis.
What side effects have been reported with Glatiramer?
Injection site erythema, Injection site pain, Injection site pruritus, Injection site mass, Vasodilatation, Rash. Serious warning: Life-threatening and fatal anaphylaxis has been reported, and can occur at any time after starting therapy, from after the first dose to years later.
Can Glatiramer be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. Pharmacovigilance and observational data have not identified a drug-associated risk of major birth defects, miscarriage, or adverse outcomes; no adverse effects in rats or rabbits. Breastfeeding: Unknown. No data on presence in human milk; low systemic exposure means clinically relevant infant exposure is not expected. Weigh benefits of breastfeeding against maternal need.
What does Glatiramer interact with?
MediHelp lists 18 known interactions for Glatiramer. Minor: 18. The most serious include Anakinra, Anti-thymocyte, Basiliximab.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
